The pharmaceutical company Farmak has upgraded its product range with a new anti hemorrhage drug Gemotran in tabloid form. Gemotran indicated for treatment of troublesome bleedings with increased fibrinolysis, as generalized (bleeding during prostate surgery and in the postoperative period, hemorrhagic complications of the fibrinolytic therapy) and local (uterine, gastrointestinal bleeding, bleeding after prostatectomy or urinary bladder interventions, tonsillectomy, cervical conization, tooth extraction in patients with hemophilia); hereditary angioedema.
Bleeding is still widespread and pressing problem in the modern practice. Unfortunately, a high mortality rate because of the massive blood loss prevails. The emergence of a new drug has not only medical but also social value. *
A healthcare specialist may choose an effective and convenient form of the Gemotran drug to deal with such a serious enemy – the bleeding.
The quality of Farmak drugs has won the trust of Ukrainian and foreign consumers because their health and life quality is the main goal for Farmak, which is once again proven by release of a new Gemotran drug in tablets.
* Andreas Meißner, Peter Schlenke / Massive Bleeding and Massive Transfusion / Transfus Med Hemother 2012; 39: 73-84 DOI:10.1159/000337250
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...